Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.
about
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infectionCross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccinationAsymmetry of Cell Division in CFSE-Based Lymphocyte Proliferation AnalysisA Protective Role for Dengue Virus-Specific CD8+ T CellsHigh epitope expression levels increase competition between T cellsAltered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model systemProtective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challengesRapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responsesIL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infectionG-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation."Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNAEndoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance.Immunodomination during peripheral vaccinia virus infection.Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age.Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchiesVariable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infectionThe CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virusNaive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominanceRelative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection.Portable flanking sequences modulate CTL epitope processing.Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes.Clinical aspects of parvovirus B19 infection.Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss.CD8+ T cell immunodominance shifts during the early stages of acute LCMV infection independently from functional avidity maturationT cell sensitivity and the outcome of viral infection.Diagnosis of in utero Parvovirus B19 infection and maternal immune response - the relevance of linear epitopes and advanced serologic testing.Synthetic biology devices and circuits for RNA-based 'smart vaccines': a propositional review.Lymph node - an organ for T-cell activation and pathogen defense.Vaccine Targeting of Subdominant CD8+ T Cell Epitopes Increases the Breadth of the T Cell Response upon Viral Challenge, but May Impair Immediate Virus Control.Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.CD8+ T cell immunodominance in lymphocytic choriomeningitis virus infection is modified in the presence of toll-like receptor agonists.The outcome of cross-priming during virus infection is not directly linked to the ability of the antigen to be cross-presented.CTL induction by cross-priming is restricted to immunodominant epitopes.
P2860
Q24564623-FB1438D0-1C6F-4CC8-A658-21F524114EFCQ24676067-AC8C624E-EFAD-467F-B1C7-7E13C6E63747Q27022977-C457D055-EDD1-43C5-81E5-D601423482ADQ27488347-2C48BF94-D8B6-4484-AC30-960CBDD20E86Q33255329-BAF6A892-00F0-4F52-A9D8-FA72B702C28AQ33754153-7BA8F910-025E-4C45-BB6E-6206FC2F443BQ33909096-1C4AF7CD-7A0A-4EF9-ADC9-F5D239F46EC3Q33916635-7641DC03-B158-4658-B9DE-1076703C7E09Q34045631-9CE54E76-2E0B-4B3B-902E-4DC92C721EC8Q34179921-A89855C4-D46D-4F30-B3F9-73DE868049DFQ34303299-C4F91D15-7EB7-4AC0-B170-5710DAA33F38Q34520218-022E31BE-7C74-42F1-8F13-818936D0FED5Q34554699-4BDEA7D3-0996-46DA-B050-42AEF2A74208Q34574914-167970D9-2F08-4D9B-891E-6B47E2414589Q34694971-22144278-3C91-4D93-A2A4-EBAB0264D2A9Q34697921-6C0A70EC-B6CD-4B32-AB03-16DF4C2117E9Q35082532-1B9D0187-8C7E-4BE4-B2B1-14E6F87C718DQ35101608-2390A5D9-2BD6-4CF6-B0F0-689E6508C3B8Q35185997-847F4530-D64C-4695-8364-26B050D946F7Q35579689-04F39B86-87DB-4896-89A6-67B96B6604EAQ35784244-C5F6E6E2-6667-40F7-B82D-0BAF2528011EQ35857498-FBD20F83-275A-4B84-B6E2-104C3A5C213DQ35871197-FD3C7548-314C-4504-9B08-1ABF47D6731AQ35944415-7829EB68-A079-4181-97C7-90A0B6DC91E5Q36099407-6D72EC5F-B95C-4AD8-8F56-157366D96827Q36267161-F04F57A3-FEF2-4D59-8E14-BE44866333AAQ36589340-F4037AA5-9B24-4305-93B2-D259D0052C4BQ36922491-E196DBA3-537B-4424-8FD2-6F6E814A0CDDQ37194982-E0F6D384-64F4-4FB4-AE5A-4381EC547DB2Q37308236-3D03FD75-B27E-47C9-8C11-D94D54F07261Q37646853-5C2DD2EE-67D1-4AB6-BC70-DA0EA6881551Q38088715-3412F827-B1FB-4B6C-B12B-AB371E1AEC3BQ38310499-7D3D0CF7-EEAE-4E93-BAD7-0474B82CEA36Q38810913-B76BB4A8-CAF8-4BA0-889C-F0F86B492593Q38908528-D5B3324D-F5A4-4F8E-853D-DD7C10FC93BBQ39142065-40E54234-7168-41D8-BB7F-EEF816A12DE3Q39584224-D71979D5-B2D9-4C32-91F5-2F8C7490EFB9Q39669234-211F3CFB-270A-42B9-A556-20F934DCB040Q39697546-922040DC-444D-404A-B123-8891624767A6Q39888117-5E588BC3-3C1C-4F08-BCA7-A5717ADA7117
P2860
Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Immunodominance of an antivira ...... s of viral protein expression.
@en
type
label
Immunodominance of an antivira ...... s of viral protein expression.
@en
prefLabel
Immunodominance of an antivira ...... s of viral protein expression.
@en
P2093
P1476
Immunodominance of an antivira ...... s of viral protein expression.
@en
P2093
Awen Gallimore
Emma Jones
Hans Christian Probst
Kathrin Tschannen
Marianne Martinic
Maries F van den Broek
Michael Basler
Tilman Dumrese
P304
P356
10.4049/JIMMUNOL.171.10.5415
P407
P577
2003-11-01T00:00:00Z